Subscribe (free)
About NaturalNews
Contact Us
Write for NaturalNews
Media Info
Advertising Info
Drug patents

Thai Government Deals Patent Blow to Big Pharma's Cancer Drug Monopoly

Thursday, August 21, 2008 by: David Gutierrez, staff writer
Tags: drug patents, health news, Natural News

Most Viewed Articles
Popular on Facebook
(NaturalNews) Health Minister Chaiya Sasomsap said that the government of Thailand will override the patents on three cancer drugs, after pressure from health activists and doctors calling on him to resign. Over the course of five years, the decision is expected to save the government of Thailand, and cost the pharmaceutical companies, more than 3 billion baht ($100 million).

It is not the first time that Thailand has issued compulsory licenses to override the patents on expensive drugs. In 2006, former Health Minister Mongkol na Songkhla overrode the patent on the HIV/AIDS medication Efavirenz, manufactured by Merck.

Mongkol said that a poor nation such as Thailand could not afford to pay patented drug prices for the 63 million people on its national health plan - 80 percent of the country's population. Soon after, he issued compulsory licenses for an Abbot Laboratories AIDS drug and a Sanofi-Aventis heart medicine.

Mongkol also announced patent overrides on three cancer drugs: Letrozole, a Novartis drug for breast cancer; Docetaxel, a Sanofi-Aventis drug for breast and lung cancer; and Erlotinib, a Roche drug for lung, ovarian and pancreatic cancer. But when Chaiya took over as health minister in February 2008, the three affected drug companies launched a lobbying effort to reverse Mongkol's decision.

Chaiya, a businessman with no history in medicine, announced that he would review the decision, calling it "politically correct ... but not legally correct." He also fired the Health Ministry's top negotiator responsible for securing lower prices for foreign drug companies. Outraged doctors and health activists immediately launched a campaign to remove Chaiya from office.

On March 10, Chaiya announced that Mongkol's initial decision would be upheld.

"The findings have convinced me to go ahead with the compulsory licenses, since the ministry's policy is to give patients good access to quality drugs at cheap prices," he said.

In February, drug company Novartis averted a compulsory license on its leukemia drug Glivec by agreeing to provide it to hundreds of Thai patients for free.
STAY INFORMED! Free subscription to the Health Ranger's email newsletter
Get breaking news alerts on GMOs, fluoride, superfoods, natural cures and more...
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.